Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Loading...

Absci Corporation

ABSINASDAQ
Healthcare
Biotechnology
$3.08
$0.22(7.69%)
U.S. Market opens in 15h 18m

Absci Corporation Fundamental Analysis

Absci Corporation (ABSI) shows weak financial fundamentals with a PE ratio of -3.91, profit margin of -40.71%, and ROE of -60.19%. The company generates $0.0B in annual revenue with weak year-over-year growth of -20.71%.

Key Strengths

Cash Position34.43%
PEG Ratio-0.92
Current Ratio5.89

Areas of Concern

ROE-60.19%
Operating Margin-42.29%
We analyze ABSI's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -3105.4/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-3105.4/100

We analyze ABSI's fundamental strength across five key dimensions:

Efficiency Score

Weak

ABSI struggles to generate sufficient returns from assets.

ROA > 10%
-46.78%

Valuation Score

Excellent

ABSI trades at attractive valuation levels.

PE < 25
-3.91
PEG Ratio < 2
-0.92

Growth Score

Moderate

ABSI shows steady but slowing expansion.

Revenue Growth > 5%
-20.71%
EPS Growth > 10%
21.67%

Financial Health Score

Excellent

ABSI maintains a strong and stable balance sheet.

Debt/Equity < 1
0.03
Current Ratio > 1
5.89

Profitability Score

Weak

ABSI struggles to sustain strong margins.

ROE > 15%
-6018.79%
Net Margin ≥ 15%
-40.71%
Positive Free Cash Flow
No

Key Financial Metrics

Is ABSI Expensive or Cheap?

P/E Ratio

ABSI trades at -3.91 times earnings. This suggests potential undervaluation.

-3.91

PEG Ratio

When adjusting for growth, ABSI's PEG of -0.92 indicates potential undervaluation.

-0.92

Price to Book

The market values Absci Corporation at 2.13 times its book value. This may indicate undervaluation.

2.13

EV/EBITDA

Enterprise value stands at -4.54 times EBITDA. This is generally considered low.

-4.54

How Well Does ABSI Make Money?

Net Profit Margin

For every $100 in sales, Absci Corporation keeps $-40.71 as profit after all expenses.

-40.71%

Operating Margin

Core operations generate -42.29 in profit for every $100 in revenue, before interest and taxes.

-42.29%

ROE

Management delivers $-60.19 in profit for every $100 of shareholder equity.

-60.19%

ROA

Absci Corporation generates $-46.78 in profit for every $100 in assets, demonstrating efficient asset deployment.

-46.78%

Following the Money - Real Cash Generation

Operating Cash Flow

Absci Corporation generates limited operating cash flow of $-84.41M, signaling weaker underlying cash strength.

$-84.41M

Free Cash Flow

Absci Corporation generates weak or negative free cash flow of $-85.70M, restricting financial flexibility.

$-85.70M

FCF Per Share

Each share generates $-0.57 in free cash annually.

$-0.57

FCF Yield

ABSI converts -17.75% of its market value into free cash.

-17.75%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-3.91

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.92

vs 25 benchmark

P/B Ratio

Price to book value ratio

2.13

vs 25 benchmark

P/S Ratio

Price to sales ratio

166.40

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.03

vs 25 benchmark

Current Ratio

Current assets to current liabilities

5.89

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.60

vs 25 benchmark

ROA

Return on assets percentage

-0.47

vs 25 benchmark

ROCE

Return on capital employed

-0.55

vs 25 benchmark

How ABSI Stacks Against Its Sector Peers

MetricABSI ValueSector AveragePerformance
P/E Ratio-3.9127.99 Better (Cheaper)
ROE-60.19%761.00% Weak
Net Margin-4071.19%-20193.00% (disorted) Weak
Debt/Equity0.030.31 Strong (Low Leverage)
Current Ratio5.894.55 Strong Liquidity
ROA-46.78%-8870.00% (disorted) Weak

ABSI outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Absci Corporation's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

84.18%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

-1210.45%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

-904.42%

Industry Style: Defensive, Growth, Innovation

Declining

Fundamental Analysis FAQ